Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2525
-0.0195 (-7.17%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2575
+0.0050 (1.98%)
After-hours: Aug 28, 2026, 7:52 PM EDT

Mereo BioPharma Group Revenue

In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K.

Revenue (ttm)
$500.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
40.32M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025500.00K--
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.62M
Aligos Therapeutics31.52M
Werewolf Therapeutics21.00M
Veru Inc.16.89M
Metagenomi Therapeutics13.56M
CervoMed331.30K
Impact BioMedical35.00K
Revenue Rankings

MREO News

More News